Warning: The NCBI web site requires JavaScript to function. more...
Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Heparin-induced thrombocytopenia (HIT) is an increasingly common clinical finding in patients presenting for cardiac transplantation. Bivalrudin, a reversible direct thrombin inhibitor, is a molecular anti-coagulant with short half-life and the potential for removal by intraoperative hemofiltration. Herein we describe the dosing and intraoperative management of bivalrudin anti-coagulation in a patient undergoing urgent cardiac transplantation in the context of recently diagnosed HIT.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on